User profiles for NICHOLAS L. SYN

Nicholas Syn

Yong Loo Lin School of Medicine, National University of Singapore
Verified email at u.nus.edu
Cited by 9478

De-novo and acquired resistance to immune checkpoint targeting

NL Syn, MWL Teng, TSK Mok, RA Soo - The Lancet Oncology, 2017 - thelancet.com
Use of immune checkpoint inhibitors targeting the programmed cell death protein-1/programmed
cell death-ligand 1 and cytotoxic T lymphocyte-associated protein-4 axes has yielded …

Exosomes in cancer nanomedicine and immunotherapy: prospects and challenges

NL Syn, L Wang, EKH Chow, CT Lim, BC Goh - Trends in biotechnology, 2017 - cell.com
Exosomes (versatile, cell-derived nanovesicles naturally endowed with exquisite target-homing
specificity and the ability to surmount in vivo biological barriers) hold substantial promise …

Survival advantage of laparoscopic versus open resection for colorectal liver metastases: a meta-analysis of individual patient data from randomized trials and …

NL Syn, T Kabir, YX Koh, HL Tan, LZ Wang… - Annals of …, 2020 - journals.lww.com
Objective: To perform an individual participant data meta-analysis using randomized trials
and propensity-score matched (PSM) studies which compared laparoscopic versus open …

Association of metabolic–bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective …

NL Syn, DE Cummings, LZ Wang, DJ Lin, JJ Zhao… - The Lancet, 2021 - thelancet.com
Background Metabolic–bariatric surgery delivers substantial weight loss and can induce
remission or improvement of obesity-related risks and complications. However, more robust …

[HTML][HTML] Steps to avoid overuse and misuse of machine learning in clinical research

V Volovici, NL Syn, A Ercole, JJ Zhao, N Liu - Nature Medicine, 2022 - nature.com
Machine learning algorithms are a powerful tool in healthcare, but sometimes perform no
better than traditional statistical techniques. Steps should be taken to ensure that algorithms …

Acquired resistance to EGFR targeted therapy in non-small cell lung cancer: Mechanisms and therapeutic strategies

SM Lim, NL Syn, BC Cho, RA Soo - Cancer treatment reviews, 2018 - Elsevier
The tyrosine kinase inhibitors (TKIs) directed at sensitizing mutations in the epidermal
growth factor receptor (EGFR) gene represents a critical pillar in non-small cell lung cancer …

Low programmed death-ligand 1–expressing subgroup outcomes of first-line immune checkpoint inhibitors in gastric or esophageal adenocarcinoma

…, YH Chan, BKJ Tan, CB Teo, NL Syn… - Journal of Clinical …, 2022 - ingentaconnect.com
PURPOSE The US Food and Drug Administration has granted regulatory approval for the
use of nivolumab—an immune checkpoint inhibitor (ICI)—in the first-line treatment of …

Immune checkpoint inhibitors in epidermal growth factor receptor mutant non-small cell lung cancer: Current controversies and future directions

RA Soo, SM Lim, NL Syn, R Teng, R Soong, TSK Mok… - Lung Cancer, 2018 - Elsevier
Major advances with the development of epidermal growth factor receptor tyrosine kinase
inhibitors and immune check-point inhibitors have ushered in a new era in lung cancer therapy…

Laparoscopic versus open resection of hepatocellular carcinoma in patients with cirrhosis: meta-analysis

T Kabir, ZZ Tan, NL Syn, E Wu, JD Lin… - British Journal of …, 2022 - academic.oup.com
Background The exact role of laparoscopic liver resection (LLR) in patients with hepatocellular
carcinoma (HCC) and underlying liver cirrhosis (LC) is not well defined. In this meta-…

[HTML][HTML] Antimicrobial peptides as biologic and immunotherapeutic agents against cancer: a comprehensive overview

R Roudi, NL Syn, M Roudbary - Frontiers in immunology, 2017 - frontiersin.org
Antimicrobial peptides (AMPs) are a pervasive and evolutionarily ancient component of innate
host defense which is present in virtually all classes of life. In recent years, evidence has …